{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:14:32Z","timestamp":1783437272724,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41433-026-04318-2","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:49:01Z","timestamp":1778053741000},"page":"1521-1529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic, clinical, and biological risk factors associated with optic nerve thinning in sickle cell disease"],"prefix":"10.1038","volume":"40","author":[{"given":"Medhi","family":"Siab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3506-7814","authenticated-orcid":false,"given":"Ali\u00e9nor","family":"Vienne-Jumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Romana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chahine","family":"Belhadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Etienne-Julan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Connes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Beral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"4318_CR1","doi-asserted-by":"publisher","first-page":"949535","DOI":"10.1100\/2012\/949535","volume":"2012","author":"SK Ballas","year":"2012","unstructured":"Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I, et al. Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. Sci World J. 2012;2012:949535.","journal-title":"Sci World J"},{"key":"4318_CR2","first-page":"OP652","volume":"77","author":"N Romayanada","year":"1973","unstructured":"Romayanada N, Goldberg MF, Green WR. Histopathology of sickle cell retinopathy. Trans Am Acad Ophthalmol Otolaryngol. 1973;77:OP652\u2013676.","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"4318_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68625-8","volume":"10","author":"A Mokrane","year":"2020","unstructured":"Mokrane A, Gazeau G, L\u00e9vy V, Fajnkuchen F, Giocanti-Aur\u00e9gan A. Analysis of the foveal microvasculature in sickle cell disease using swept-source optical coherence tomography angiography. Sci Rep. 2020;10:11795.","journal-title":"Sci Rep"},{"key":"4318_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0002-9394(71)90429-6","volume":"71","author":"MF Goldberg","year":"1971","unstructured":"Goldberg MF. Classification and pathogenesis of proliferative sickle retinopathy. Am J Ophthalmol. 1971;71:649\u201365.","journal-title":"Am J Ophthalmol"},{"key":"4318_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/archophthalmol.2010.357","volume":"129","author":"RK Murthy","year":"2011","unstructured":"Murthy RK, Grover S, Chalam KV. Temporal macular thinning on spectral-domain optical coherence tomography in proliferative sickle cell retinopathy. Arch Ophthalmol. 2011;129:247\u20139.","journal-title":"Arch Ophthalmol"},{"key":"4318_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/bjophthalmol-2019-314567","volume":"104","author":"G Lynch","year":"2020","unstructured":"Lynch G, Scott AW, Linz MO, Han I, Andrade Romo JS, Linderman RE, et al. Foveal avascular zone morphology and parafoveal capillary perfusion in sickle cell retinopathy. Br J Ophthalmol. 2020;104:473\u20139.","journal-title":"Br J Ophthalmol"},{"key":"4318_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ajo.2016.10.022","volume":"174","author":"LA Rhodes","year":"2017","unstructured":"Rhodes LA, Huisingh CE, Quinn AE, McGwin GJ, LaRussa F, Box D, et al. Comparison of Bruch\u2019s membrane opening\u2013minimum rim width among those with normal ocular health by race. Am J Ophthalmol. 2017;174:113\u20138.","journal-title":"Am J Ophthalmol"},{"key":"4318_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ophtha.2012.09.055","volume":"120","author":"BC Chauhan","year":"2013","unstructured":"Chauhan BC, O\u2019Leary N, AlMobarak FA, Reis ASC, Yang H, Sharpe GP, et al. Enhanced detection of open-angle glaucoma with an anatomically accurate optical coherence tomography\u2013derived neuroretinal rim parameter. Ophthalmology. 2013;120:535\u201343.","journal-title":"Ophthalmology"},{"key":"4318_CR9","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1167\/iovs.11-9309","volume":"53","author":"ASC Reis","year":"2012","unstructured":"Reis ASC, O\u2019Leary N, Yang H, Sharpe GP, Nicolela MT, Burgoyne CF, et al. Influence of clinically invisible, but optical coherence tomography detected, optic disc margin anatomy on neuroretinal rim evaluation. Investig Ophthalmol Vis Sci. 2012;53:1852\u201360.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4318_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0002-9394(88)90191-2","volume":"105","author":"ML Slavin","year":"1988","unstructured":"Slavin ML, Barondes MJ. Ischemic optic neuropathy in sickle cell disease. Am J Ophthalmol. 1988;105:212\u20133.","journal-title":"Am J Ophthalmol"},{"key":"4318_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1212\/WNL.0000000000012125","volume":"97","author":"A Aytulun","year":"2021","unstructured":"Aytulun A, Cruz-Herranz A, Aktas O, Balcer LJ, Balk L, Barboni P, et al. APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies. Neurology. 2021;97:68\u201379.","journal-title":"Neurology"},{"key":"4318_CR12","doi-asserted-by":"publisher","first-page":"e34823","DOI":"10.1371\/journal.pone.0034823","volume":"7","author":"P Tewarie","year":"2012","unstructured":"Tewarie P, Balk L, Costello F, Green A, Martin R, Schippling S, et al. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE. 2012;7:e34823.","journal-title":"PLoS ONE"},{"key":"4318_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/09286586.2016.1259636","volume":"24","author":"G Ying","year":"2017","unstructured":"Ying G, Maguire MG, Glynn R, Rosner B. Tutorial on biostatistics: linear regression analysis of continuous correlated eye data. Ophthalmic Epidemiol. 2017;24:130\u201340.","journal-title":"Ophthalmic Epidemiol"},{"key":"4318_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajo.2015.12.023","volume":"164","author":"W Minvielle","year":"2016","unstructured":"Minvielle W, Caillaux V, Cohen SY, Chasset F, Zambrowski O, Mi\u00e8re A. Macular microangiopathy in sickle cell disease using optical coherence tomography angiography. Am J Ophthalmol. 2016;164:137\u201344.","journal-title":"Am J Ophthalmol"},{"key":"4318_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/bjo.74.3.172","volume":"74","author":"PD Fox","year":"1990","unstructured":"Fox PD, Dunn DT, Morris JS, Serjeant GR. Risk factors for proliferative sickle retinopathy. Br J Ophthalmol. 1990;74:172\u20136.","journal-title":"Br J Ophthalmol"},{"key":"4318_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ajo.2017.02.007","volume":"177","author":"IC Han","year":"2017","unstructured":"Han IC, Tadarati M, Pacheco KD, Scott AW. Evaluation of macular vascular abnormalities identified by optical coherence tomography angiography in sickle cell disease. Am J Ophthalmol. 2017;177:90\u201399.","journal-title":"Am J Ophthalmol"},{"key":"4318_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.oret.2023.09.005","volume":"8","author":"S Hoyek","year":"2024","unstructured":"Hoyek S, Lemire C, Halawa O, Altamirano-Lamarque F, Gonzalez E, Patel NA. Longitudinal assessment of macular thickness and microvascular changes in children with sickle cell disease. Ophthalmol Retina. 2024;8:184\u201394.","journal-title":"Ophthalmol Retina"},{"key":"4318_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ajo.2012.09.015","volume":"155","author":"CC Chow","year":"2013","unstructured":"Chow CC, Shah RJ, Lim JI, Chau FY, Hallak JA, Vajaranant TS. Peripapillary retinal nerve fiber layer thickness in sickle-cell hemoglobinopathies using spectral-domain optical coherence tomography. Am J Ophthalmol. 2013;155:456\u20134.e2.","journal-title":"Am J Ophthalmol"},{"key":"4318_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.joco.2019.01.012","volume":"31","author":"MO Ulusoy","year":"2019","unstructured":"Ulusoy MO, T\u00fcrk H, K\u0131van\u00e7 SA. Spectral domain optical coherence tomography findings in Turkish sickle-cell disease and beta thalassemia major patients. J Curr Ophthalmol. 2019;31:275\u201380.","journal-title":"J Curr Ophthalmol"},{"key":"4318_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ajo.2019.02.006","volume":"202","author":"AT Thavikulwat","year":"2019","unstructured":"Thavikulwat AT, Cao D, Vajaranant TS, Lim JI. Longitudinal Study of Peripapillary Thinning in Sickle Cell Hemoglobinopathies. Am J Ophthalmol. 2019;202:30\u201336.","journal-title":"Am J Ophthalmol"},{"key":"4318_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/IAE.0000000000000309","volume":"35","author":"F Brasileiro","year":"2015","unstructured":"Brasileiro F, Martins TT, Campos SB, Andrade Neto JL, Bravo-Filho VT, Ara\u00fajo AS, et al. Macular and peripapillary spectral domain optical coherence tomography changes in sickle cell retinopathy. Retina. 2015;35:257\u201363.","journal-title":"Retina"},{"key":"4318_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2020.11.019","volume":"224","author":"S Fares","year":"2021","unstructured":"Fares S, Hajjar S, Romana M, Connes P, Acomat M, Zorobabel C, et al. Sickle cell maculopathy: microstructural analysis using OCTA and identification of genetic, systemic, and biological risk factors. Am J Ophthalmol. 2021;224:7\u201317.","journal-title":"Am J Ophthalmol"},{"key":"4318_CR23","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/bjophthalmol-2014-305532","volume":"99","author":"R Mathew","year":"2015","unstructured":"Mathew R, Bafiq R, Ramu J, Pearce E, Richardson M, Drasar E, et al. Spectral domain optical coherence tomography in patients with sickle cell disease. Br J Ophthalmol. 2015;99:967\u201372.","journal-title":"Br J Ophthalmol"},{"key":"4318_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jcjo.2017.10.006","volume":"53","author":"WS Lim","year":"2018","unstructured":"Lim WS, Magan T, Mahroo OA, Hysi PG, Helou J, Mohamed MD. Retinal thickness measurements in sickle cell patients with HbSS and HbSC genotype. Can J Ophthalmol. 2018;53:420\u20134.","journal-title":"Can J Ophthalmol"},{"key":"4318_CR25","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ajh.21475","volume":"84","author":"GJ Kato","year":"2009","unstructured":"Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol. 2009;84:618\u201325.","journal-title":"Am J Hematol"},{"key":"4318_CR26","doi-asserted-by":"publisher","first-page":"e0193582","DOI":"10.1371\/journal.pone.0193582","volume":"13","author":"L Dell\u2019Arti","year":"2018","unstructured":"Dell\u2019Arti L, Barteselli G, Riva L, Carini E, Graziadei G, Benatti E, et al. Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula. PLoS ONE. 2018;13:e0193582.","journal-title":"PLoS ONE"},{"key":"4318_CR27","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41433-019-0604-y","volume":"34","author":"J Cano","year":"2020","unstructured":"Cano J, Farzad S, Khansari MM, Tan O, Huang D, Lim JI, et al. Relating retinal blood flow and vessel morphology in sickle cell retinopathy. Eye. 2020;34:886\u201391.","journal-title":"Eye"},{"key":"4318_CR28","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1167\/iovs.17-23647","volume":"59","author":"M Shahidi","year":"2018","unstructured":"Shahidi M, Felder AE, Tan O, Blair NP, Huang D. Retinal oxygen delivery and metabolism in healthy and sickle cell retinopathy subjects. Investig Ophthalmol Vis Sci. 2018;59:1905\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4318_CR29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2147\/OPTH.S195168","volume":"13","author":"SA Hussnain","year":"2019","unstructured":"Hussnain SA, Coady PA, Slade MD, Carbonella J, Pashankar F, Adelman RA, et al. Hemoglobin level and macular thinning in sickle cell disease. Clin Ophthalmol. 2019;13:627\u201332.","journal-title":"Clin Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04318-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04318-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04318-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:21:31Z","timestamp":1783434091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04318-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4318"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04318-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7667965\/v1","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"21 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study involves human participants, and the study was approved by the \u2019Comit\u00e9 Consultatif de Protection des Personnes dans la Recherche Biom\u00e9dicale\u2019 and maintained adherence to the Declaration of Helsinki for research involving human subjects. Informed consent was obtained from all participants before study enrolment. Participants gave informed consent to participate in the study before taking part.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}